Literature DB >> 81271

Giant cell arteritis (cranial arteritis, polymyalgia rheumatica).

M Mumenthaler.   

Abstract

Giant cell arteritis, which is probably due to disturbed immune mechanisms, has a spectrum of clinical symptoms in elderly people. In nearly all cases such general signs as loss of appetite, loss of weight and fever are present. The sedimentation rate is almost without exception about 100 mm in the first hour. The two most frequent and typical clinical syndromes are polymyalgia rheumatica and cranial arteritis. The polymyalgia rheumatica is characterized by periarticular pain which is mostly symmetrical and accentuated in the shoulder girdle. Increasingly severe temporal headache and ocular distrubances are found with cranial arteritis in more than 50% of cases. A combination of both diseases is frequent. Other arterial branches are rarely involved. The course of the disease is over a period of 1 1/2 to 2 years. Treatment with corticosteroids is indicated mainly because of the severe ocular complications with blindness. It should begin immediately, be intensive and last over a long period. Regular followup is necessary over several years in order to avoid relapses.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 81271     DOI: 10.1007/BF00312878

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  110 in total

1.  [Myalgia in primary hyperparathyroidism: differential diagnosis from polymyalgia rheumatica].

Authors:  J C Gerster; T L Vischer; A Panchaud; P Burkehardt; E Courvoisier; G H Fallet
Journal:  Schweiz Med Wochenschr       Date:  1975-05-10

2.  Fatal granulomatosis of the respiratory tract (lethal midline granuloma-Wegener's granulomatosis).

Authors:  I M BLATT; H S SELTZER; P RUBIN; A C FURSTENBERG; J H MAXWELL; W J SCHULL
Journal:  AMA Arch Otolaryngol       Date:  1959-12

3.  Myalgic syndrome with constitutional effects; polymyalgia rheumatica.

Authors:  H S BARBER
Journal:  Ann Rheum Dis       Date:  1957-06       Impact factor: 19.103

4.  [Giant-cell arteriotis in the aged (temporal arteriotis)].

Authors:  P Marx
Journal:  Nervenarzt       Date:  1976-04       Impact factor: 1.214

5.  Anterior ischaemic optic neuropathy. III. Treatment, prophylaxis, and differential diagnosis.

Authors:  S S Hayreh
Journal:  Br J Ophthalmol       Date:  1974-12       Impact factor: 4.638

6.  [A case of Horton's disease with extensive necrosis at the cephalic level].

Authors:  M Samson; P Augustin; L Verdure; A Fondimare
Journal:  Rev Otoneuroophtalmol       Date:  1974 Mar-Apr

Review 7.  [Differential diagnosis of arteritis].

Authors:  R Emmrich
Journal:  Z Gesamte Inn Med       Date:  1974-04-01

8.  Thyrotoxicosis and giant-cell arteritis.

Authors:  R D Thomas; D N Croft
Journal:  Br Med J       Date:  1974-05-25

9.  Cortical blindness in cranial arteritis.

Authors:  I H Chisholm
Journal:  Br J Ophthalmol       Date:  1975-06       Impact factor: 4.638

10.  Hepatitis-B antibody in polymyalgia Rheumatica.

Authors:  P A Bacon; S M Doherty; A J Zuckerman
Journal:  Lancet       Date:  1975-09-13       Impact factor: 79.321

View more
  2 in total

1.  Intracranial giant cell arteritis.

Authors:  E Russi; M Aebi; R Kraus-Ruppert; M Mumenthaler
Journal:  J Neurol       Date:  1979-10       Impact factor: 4.849

2.  Immune complexes, rheumatoid factors, and cellular immunological parameters in patients with giant cell arteritis.

Authors:  B E Malmvall; B A Bengtsson; L A Nilsson; L M Bjursten
Journal:  Ann Rheum Dis       Date:  1981-06       Impact factor: 19.103

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.